5-Amino-1MQ
5-Amino-1MQ is a small molecule NNMT (nicotinamide N-methyltransferase) inhibitor that enhances cellular NAD+ levels and mitochondrial function.
View research5-Amino-1MQ is a small molecule NNMT (nicotinamide N-methyltransferase) inhibitor that enhances cellular NAD+ levels and mitochondrial function.
View researchAdalank (N-Acetyl Selank Amidate) is an enhanced synthetic derivative of Selank peptide, featuring N-terminal acetylation and C-terminal amidation for superior stability and blood-brain barrier…
View researchAdamax is a synthetic nootropic peptide and enhanced derivative of Semax, featuring N-terminal acetylation and C-terminal adamantane modification for superior stability and blood-brain barrier…
View researchAdipotide (Prohibitin‑TP01) is a chimeric, adipose‑vasculature–targeted peptidomimetic that homes to prohibitin/annexin A2 on white adipose tissue endothelium and delivers a pro‑apoptotic…
View researchAHK-Cu (Copper Tripeptide-3) is a synthetic copper-binding tripeptide composed of Alanine-Histidine-Lysine complexed with a copper ion (Cu²⁺).
View researchAOD-9604 is a modified fragment of human growth hormone (hGH amino acids 177-191) with an N-terminal tyrosine, developed by Professor Frank Ng at Monash University in collaboration with Metabolic…
View researchAra 290 (Cibinetide) is an engineered 11-amino acid peptide derived from erythropoietin that activates the Innate Repair Receptor (IRR) to provide tissue-protective effects without stimulating red…
View researchBioglutide (NA-931) is a first-in-class oral quadruple receptor agonist targeting IGF-1, GLP-1, GIP, and glucagon receptors simultaneously.
View researchBPC-157 is a synthetic pentadecapeptide (15 amino acids) derived from a protective protein found in human gastric juice.
View researchBromantane (Ladasten) is a unique adamantane derivative and actoprotector developed in the 1980s at the Zakusov State Institute of Pharmacology in Russia, originally field-tested by the Soviet…
View researchCagrilintide (AM833) is a novel long-acting lipidated amylin analog that acts as a dual amylin and calcitonin receptor agonist.
View researchCardiogen (Ala-Glu-Asp-Arg / AEDR) is a synthetic tetrapeptide bioregulator developed by Professor Vladimir Khavinson at the St.
View research